Indication: It is used to treat chloroquine-sensitive malignant malaria, vivax malaria and malaria malaria. It can also be used to suppress the symptoms of malaria. It can also be used to treat extraintestinal amebiasis, connective tissue diseases, photosensitivity diseases (such as sunburn erythema), etc.

Indication: Nitroimidazole antiprotozoal drugs. Mainly used to treat the following diseases: 1. Urethritis and vaginitis caused by Trichomonas vaginalis; 2. Intestinal amebiasis; 3. Hepatic amebiasis; 4. Giardiasis.

Indication: 1. Used to treat various diseases caused by anaerobic bacteria (Bacteroides fragilis, Bacteroides distichous, Bacteroides ovale, Bacteroides thetaiotaomicron, Bacteroides vulgaris, Clostridium, Eubacterium, Peptococcus and Peptostreptococcus, Helicobacter pylori, Bacteroides melanin, Fusobacterium, CO2-phagocytosis, Bacteroides gingivalis, etc.); 2. Diseases caused by Trichomonas and Giardia infection in the urogenital tract of men and women (such as vaginal trichomoniasis, etc.); 3. Diseases caused by intestinal and hepatic amoebiasis (including amoebic dysentery and amoebic liver abscess) and intestinal and hepatic amoeba infection; used to prevent and treat anaerobic infections after surgery in various departments.

Indication: This product is suitable for infections caused by sensitive protozoa and anaerobic bacteria. 1. For male and female urogenital tract infections caused by Trichomonas. 2. For intestinal and hepatic amoebiasis caused by amoeba (including amoebic dysentery and amoebic liver abscess). 3. For giardiasis. 4. For anaerobic infections: such as sepsis, meningitis, peritonitis, postoperative wound infection, postpartum sepsis, septic abortion, endometritis and other infections caused by sensitive bacteria. 5. For the prevention of various postoperative anaerobic infections.

Indication: This product is suitable for infections caused by sensitive protozoa and anaerobic bacteria: 1. For male and female urogenital tract infections caused by Trichomonas; 2. For intestinal and hepatic amoebiasis caused by amoeba (including amoebic dysentery and amoebic liver abscess); 3. For giardiasis; 4. For anaerobic infections: such as sepsis, meningitis, peritonitis, postoperative wound infection, postpartum sepsis, septic abortion, endometritis and other infections caused by sensitive bacteria; 5. For the prevention of various postoperative anaerobic infections.

Indication: This product is suitable for infections caused by sensitive protozoa and anaerobic bacteria: 1. For male and female urogenital tract infections caused by Trichomonas; 2. For intestinal and hepatic amoebiasis caused by amoeba (including amoebic dysentery and amoebic liver abscess); 3. For giardiasis; 4. For anaerobic infections: such as sepsis, meningitis, peritonitis, postoperative wound infection, postpartum sepsis, septic abortion, endometritis and other infections caused by sensitive bacteria; 5. For the prevention of various postoperative anaerobic infections.

Indication: This product is suitable for infections caused by sensitive protozoa and anaerobic bacteria: 1. For male and female urogenital tract infections caused by Trichomonas; 2. For intestinal and hepatic amoebiasis (including amoebic dysentery and amoebic liver abscess) caused by amoeba; 3. For giardiasis; 4. For anaerobic infections: such as sepsis, meningitis, peritonitis, postoperative wound infection, postpartum sepsis, septic abortion, endometritis and other infections caused by sensitive bacteria; 5. For the prevention of various postoperative anaerobic infections.

Indication: This product is suitable for infections caused by sensitive protozoa and anaerobic bacteria: 1. For male and female urogenital tract infections caused by Trichomonas; 2. For intestinal and hepatic amoebiasis (including amoebic dysentery and amoebic liver abscess) caused by amoeba; 3. For giardiasis; 4. For anaerobic infections: such as sepsis, meningitis, peritonitis, postoperative wound infection, postpartum sepsis, septic abortion, endometritis and other infections caused by sensitive bacteria; 5. For the prevention of various postoperative anaerobic infections.

Indication: INDICATIONS AND USAGE
Metronidazole tablets are indicated for the treatment of T. vaginalis Metronidazole tablets are indicated in the treatment of asymptomatic T. vaginalis T. vaginalis Metronidazole tablets are indicated in the treatment of acute intestinal amebiasis (amebic dysentery) and amebic liver abscess. In amebic liver abscess, metronidazole tablets therapy does not obviate the need for aspiration or drainage of pus. Metronidazole tablets are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Indicated surgical procedures should be performed in conjunction with metronidazole tablets therapy. In a mixed aerobic and anaerobic infection, antimicrobials appropriate for the treatment of the aerobic infection should be used in addition to metronidazole tablets. INTRA-ABDOMINAL INFECTIONS, Bacteroides B. fragilis, B. distasonis, B. thetaiotaomicron, B. vulgatus Clostridium Eubacterium Peptococcus , Peptostreptococcus SKIN AND SKIN STRUCTURE INFECTIONS Bacteroides B. fragilis Clostridium Peptococcus , Peptostreptococcus Fusobacterium GYNECOLOGIC INFECTIONS, including endometritis, endomyometritis, tubo-ovarian abscess, and postsurgical vaginal cuff infection, caused by Bacteroides B. fragilis Clostridium Peptococcus , Peptostreptococcus Fusobacterium BACTERIAL SEPTICEMIA Bacteroides B. fragilis Clostridium BONE AND JOINT INFECTIONS, Bacteroides B. fragilis CENTRAL NERVOUS SYSTEM (CNS) INFECTIONS, including meningitis and brain abscess, caused by Bacteroides B. fragilis LOWER RESPIRATORY TRACT INFECTIONS, including pneumonia, empyema, and lung abscess, caused by Bacteroides B. fragilis ENDOCARDITIS Bacteroides B. fragilis To reduce the development of drug-resistant bacteria and maintain the effectiveness of metronidazole tablets and other antibacterial drugs, metronidazole tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Symptomatic Trichomoniasis
Metronidazole tablets are indicated for the treatment of T. vaginalis
Asymptomatic Trichomoniasis
Metronidazole tablets are indicated in the treatment of asymptomatic T. vaginalis
Treatment of Asymptomatic Sexual Partners
T. vaginalis
Amebiasis
Metronidazole tablets are indicated in the treatment of acute intestinal amebiasis (amebic dysentery) and amebic liver abscess. In amebic liver abscess, metronidazole tablets therapy does not obviate the need for aspiration or drainage of pus.
Anaerobic Bacterial Infections
Metronidazole tablets are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Indicated surgical procedures should be performed in conjunction with metronidazole tablets therapy. In a mixed aerobic and anaerobic infection, antimicrobials appropriate for the treatment of the aerobic infection should be used in addition to metronidazole tablets. INTRA-ABDOMINAL INFECTIONS, Bacteroides B. fragilis B. fragilis, B. distasonis, B. ovatus, B. thetaiotaomicron, B. vulgatus Clostridium Eubacterium Peptococcus , Peptostreptococcus SKIN AND SKIN STRUCTURE INFECTIONS Bacteroides B. fragilis Clostridium Peptococcus , Peptostreptococcus Fusobacterium GYNECOLOGIC INFECTIONS, including endometritis, endomyometritis, tubo-ovarian abscess, and postsurgical vaginal cuff infection, caused by Bacteroides B. fragilis Clostridium Peptococcus , Peptostreptococcus Fusobacterium BACTERIAL SEPTICEMIA Bacteroides B. fragilis Clostridium BONE AND JOINT INFECTIONS, Bacteroides B. fragilis CENTRAL NERVOUS SYSTEM (CNS) INFECTIONS, including meningitis and brain abscess, caused by Bacteroides B. fragilis LOWER RESPIRATORY TRACT INFECTIONS, including pneumonia, empyema, and lung abscess, caused by Bacteroides B. fragilis ENDOCARDITIS Bacteroides B. fragilis To reduce the development of drug-resistant bacteria and maintain the effectiveness of metronidazole tablets and other antibacterial drugs, metronidazole tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.